Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1969;40(6):807–818.

Active immunization against Plasmodium berghei malaria in mice, using different preparations of plasmodial antigen and different pathways of administration*

Christoph Jerusalem, Wynand Eling
PMCID: PMC2554776  PMID: 5307595

Abstract

With regard to the effectiveness of the antigens in inducing clinical immunity against malaria parasites, the minimum amount of living antigen developed in mice during controlled low parasitaemia with Plasmodium berghei has been estimated and compared with the amount of non-living antigen obtained by various methods of freeing parasites from their erythrocyte hosts.

Whereas about 100 mg of living antigen per kg of body-weight are sufficient to induce a degree of hyperimmunity, 1240 mg/kg of a freshly prepared crude antigen are necessary to enable the mice to survive a challenge infection while 3500 mg—7000 mg/kg of a vaccine prepared from freshly isolated plasmodia are necessary to produce a degree of immunity comparable with hyperimmunity. It appears, therefore, that every manipulation of the parasitized erythrocyte or the isolated plasmodium outside the host organism, as well as a storage time in excess of 36 hours, causes a reduction in antigenicity, up to a factor of 10-2. However, this decrease in antigenicity is disproportionate compared with the reduced rate of infectivity of stored, parasitized erythrocytes and isolated parasites. After an incubation period of 18 hours, the ID100 increases from 2 × 10 to 5 × 107 parasites. Therefore, the differences between the essential amount of living plasmodia and non-living antigen may be due to other, hitherto unknown, factors and not exclusively to degradation of the most important antigen.

The saponin method of freeing parasites from their erythrocyte hosts was found to yield the purest antigen. Preparations of parasites obtained by treating parasitized erythrocytes with anti-erythrocyte serum or with formalin were highly contaminated with remnants of the host cells and showed no better antigenic qualities than the parasites isolated by means of saponin.

Since the decrease of antigenicity associated with harvesting and isolation procedures is constant, vaccination with a fractionated antigen pool should be possible.

Full text

PDF
807

Images in this article

814-1FIG. 4
on p.814-1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOWMAN I. B., GRANT P. T., KERMACK W. O. The metabolism of Plasmodium berghei, the malaria parasite of rodents. I. The preparation of the erythrocytic form of P. berghei separated from the host cell. Exp Parasitol. 1960 Apr;9:131–136. doi: 10.1016/0014-4894(60)90021-7. [DOI] [PubMed] [Google Scholar]
  2. CURTAIN C. C., KIDSON C., CHAMPNESS D. L., GORMAN J. G. MALARIA ANTIBODY CONTENT OF GAMMA 2-7S GLOBULIN IN TROPICAL POPULATIONS. Nature. 1964 Sep 26;203:1366–1367. doi: 10.1038/2031366a0. [DOI] [PubMed] [Google Scholar]
  3. Coombs R. R. Immunopathology. Br Med J. 1968 Mar 9;1(5592):597–602. doi: 10.1136/bmj.1.5592.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Freund J., Thomson K. J., Sommer H. E., Walter A. W., Schenkein E. L. IMMUNIZATION OF RHESUS MONKEYS AGAINST MALARIAL INFECTION (P. KNOWLESI) WITH KILLED PARASITES AND ADJUVANTS. Science. 1945 Aug 24;102(2643):202–204. doi: 10.1126/science.102.2643.202. [DOI] [PubMed] [Google Scholar]
  5. HAUG H. Die Treffermethode, ein Verfahren zur quantitativen Analyse im histologischen Schnitt. Z Anat Entwicklungsgesch. 1955;118(4):302–312. [PubMed] [Google Scholar]
  6. HENNIG A. Das Problem der Kernmessung; eine Zusammenfassung und Erweiterung der mikroskopischen Messtechnik. Mikroskopie. 1957 Sep;12(5-6):174–202. [PubMed] [Google Scholar]
  7. Jerusalem C. Active immunization against malaria (Plasmodium berghei). I. Definition of antimalarial immunity. Z Tropenmed Parasitol. 1968 Jun;19(2):171–181. [PubMed] [Google Scholar]
  8. Jerusalem C., Kretschmar W. Untersuchungen zur Nuklenisäuresynthese der Malaria-Erreger an milchernährten Mäusen (Plasmodium berghel) Z Parasitenkd. 1967;28(3):193–210. doi: 10.1007/BF00260260. [DOI] [PubMed] [Google Scholar]
  9. Jerusalem C. Pyrimethamin-Therapie kombiniert mit p-Aminobenzoesäure-freier Diät bei der experimentellen Malariainfektion (Plasmodium berghei) Klin Wochenschr. 1966 Oct 1;44(19):1156–1158. doi: 10.1007/BF01745548. [DOI] [PubMed] [Google Scholar]
  10. Jerusalem S., Bruchhausen D. Exotoxin in malaria infection (Plasmodium berghei). Experientia. 1967 Jan 15;23(1):14–15. doi: 10.1007/BF02142239. [DOI] [PubMed] [Google Scholar]
  11. SPIRAD, ZUCKERMAN A. Antigenic structure of Plasmodium vinckei. Science. 1962 Aug 17;137(3529):536–537. doi: 10.1126/science.137.3529.536. [DOI] [PubMed] [Google Scholar]
  12. Targett G. A., Fulton J. D. Immunization of rhesus monkeys against Plasmodium knowlesi malaria. Exp Parasitol. 1965 Oct;17(2):180–193. doi: 10.1016/0014-4894(65)90020-2. [DOI] [PubMed] [Google Scholar]
  13. Targett G. A., Voller A. Studies on antibody levels during vaccination of rhesus monkeys against Plasmodium knowlesi. Br Med J. 1965 Nov 6;2(5470):1104–1106. doi: 10.1136/bmj.2.5470.1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Voller A., Richards W. H. An attempt to vaccinate owl monkeys (Aotus trivirgatus) against falciparum malaria. Lancet. 1968 Nov 30;2(7579):1172–1174. doi: 10.1016/s0140-6736(68)91644-9. [DOI] [PubMed] [Google Scholar]
  15. Weiss M. L., De Giusti D. L. Active immunization against Plasmodium berghei malaria in mice. Am J Trop Med Hyg. 1966 Jul;15(4):472–482. doi: 10.4269/ajtmh.1966.15.472. [DOI] [PubMed] [Google Scholar]
  16. Zuckerman A., Hamburger Y., Spira D. Active immunization of rats with a cell-free extract of the erythrocytic parasites of Plasmodium berghei. Exp Parasitol. 1967 Aug;21(1):84–97. doi: 10.1016/0014-4894(67)90071-9. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES